BACKGROUND: Although schizophrenia has been characterized by disruptions to neural synchrony, it remains unknown whether these disturbances are related to symptoms and loss of grey matter. We examined relations between 40 Hz Gamma band synchrony and grey matter in patients with schizophrenia at first episode and after 2.5 years. METHODS: From an initial recruitment of 35 medicated patients with a first episode of schizophrenia, 25 patients completed clinical and oddball task-elicited Gamma synchrony within 3 months of health service contact and again after 2.5 years, 23 completed magnetic resonance imaging (MRI) at these time points, and 13 completed all sessions. We compared patients with 35 matched healthy controls. We identified early (0-150 ms) and late (250-500 ms) peaks in Gamma synchrony locked to oddball targets, and we analyzed MRI data using voxel-based morphometry. We evaluated group and test-retest differences using repeated-measures analyses of variance. RESULTS: Compared with controls, at first contact, patients with a first episode of schizophrenia showed a disruption to the laterality of early Gamma synchrony and global reduction in late Gamma synchrony, with a corresponding loss of fronto-temporal-parietal grey matter. Gamma synchrony was increased at follow-up among patients with a first episode of schizophrenia. It related negatively to further loss of grey matter, but positively to improvement in reality distortion symptoms. These relations could not be explained by medication dose. LIMITATIONS: Our study did not include unmedicated patients or normative follow-up testing. CONCLUSION: Gamma synchrony may track the progression of schizophrenia from first episode. An increase in Gamma synchrony over time might reflect an attempt to adapt to a progressive loss of cortical grey matter and associated changes in cognitive and emotional function.
BACKGROUND: Although schizophrenia has been characterized by disruptions to neural synchrony, it remains unknown whether these disturbances are related to symptoms and loss of grey matter. We examined relations between 40 Hz Gamma band synchrony and grey matter in patients with schizophrenia at first episode and after 2.5 years. METHODS: From an initial recruitment of 35 medicated patients with a first episode of schizophrenia, 25 patients completed clinical and oddball task-elicited Gamma synchrony within 3 months of health service contact and again after 2.5 years, 23 completed magnetic resonance imaging (MRI) at these time points, and 13 completed all sessions. We compared patients with 35 matched healthy controls. We identified early (0-150 ms) and late (250-500 ms) peaks in Gamma synchrony locked to oddball targets, and we analyzed MRI data using voxel-based morphometry. We evaluated group and test-retest differences using repeated-measures analyses of variance. RESULTS: Compared with controls, at first contact, patients with a first episode of schizophrenia showed a disruption to the laterality of early Gamma synchrony and global reduction in late Gamma synchrony, with a corresponding loss of fronto-temporal-parietal grey matter. Gamma synchrony was increased at follow-up among patients with a first episode of schizophrenia. It related negatively to further loss of grey matter, but positively to improvement in reality distortion symptoms. These relations could not be explained by medication dose. LIMITATIONS: Our study did not include unmedicated patients or normative follow-up testing. CONCLUSION: Gamma synchrony may track the progression of schizophrenia from first episode. An increase in Gamma synchrony over time might reflect an attempt to adapt to a progressive loss of cortical grey matter and associated changes in cognitive and emotional function.
Authors: M Breakspear; J R Terry; K J Friston; A W F Harris; L M Williams; K Brown; J Brennan; E Gordon Journal: Neuroimage Date: 2003-09 Impact factor: 6.556
Authors: Kevin M Spencer; Paul G Nestor; Ruth Perlmutter; Margaret A Niznikiewicz; Meredith C Klump; Melissa Frumin; Martha E Shenton; Robert W McCarley Journal: Proc Natl Acad Sci U S A Date: 2004-11-16 Impact factor: 11.205
Authors: Robert H Paul; C Richard Clark; Jeffrey Lawrence; Elkhonon Goldberg; Leanne M Williams; Nicholas Cooper; Ronald A Cohen; Adam M Brickman; Evian Gordon Journal: J Integr Neurosci Date: 2005-03 Impact factor: 2.117
Authors: Tom F D Farrow; Thomas J Whitford; Leanne M Williams; Lavier Gomes; Anthony W F Harris Journal: Biol Psychiatry Date: 2005-07-05 Impact factor: 13.382
Authors: Anthony Harris; John Brennan; Josephine Anderson; Anne Taylor; Mark Sanbrook; Dianne Fitzgerald; Sara Lucas; Antoinette Redoblado-Hodge; Lavier Gomes; Evian Gordon Journal: Aust N Z J Psychiatry Date: 2005 Jan-Feb Impact factor: 5.598
Authors: Leanne M Williams; Thomas J Whitford; Marie Nagy; Gary Flynn; Anthony W F Harris; Steven M Silverstein; Evian Gordon Journal: J Psychiatry Neurosci Date: 2009-07 Impact factor: 6.186
Authors: Veronica B Perez; Brian J Roach; Scott W Woods; Vinod H Srihari; Thomas H McGlashan; Judith M Ford; Daniel H Mathalon Journal: Suppl Clin Neurophysiol Date: 2013
Authors: Hamid M Abdolmaleky; Adam C Gower; Chen-Khuan Wong; Jiayi W Cox; Xiaoling Zhang; Arunthathi Thiagalingam; Rahim Shafa; Vadivelu Sivaraman; Jin-Rong Zhou; Sam Thiagalingam Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-11-23 Impact factor: 3.568
Authors: Veronica B Perez; Judith M Ford; Brian J Roach; Rachel L Loewy; Barbara K Stuart; Sophia Vinogradov; Daniel H Mathalon Journal: Schizophr Bull Date: 2011-10-11 Impact factor: 9.306